Close Menu Congressman Kurt Schrader

Health Care

H.R.7757
Health Care
Long-Term Care Pharmacy Definition Act of 2020

Rep. Schrader introduced the bipartisan Long-Term Care Pharmacy Definition Act of 2020. Long-term care pharmacies provide medication management for the nearly 2 million seniors currently in long-term ...

Read More
H.R.6134
Education, Health Care, Animal Welfare
VET MED Act

Rep. Schrader introduced the bipartisan Veterinary Education and Training Minimizes Educational Debt (VET MED) Act with Rep. Ted Yoho (R-FL). They are both veterinarians and co-chairs of the Veterinar...

Read More
Health Care
Rep. Schrader Introduces Bipartisan Bill to Improve Access to Gene Therapies

For Immediate Release February 13, 2020 Contact: Larkin Parker, 202-225-5711 Rep. Schrader Introduces Bipartisan Bill to Improve Access to Gene Therapies WASHINGTON, D.C. –Today, Rep. Kurt Schrader (...

Read More
H.R.5882
Health Care
GENE Therapy Payment Act

Kurt Schrader introduced the bipartisan GENE Therapy Payment Act. This legislation will help those with life-threatening illnesses who can benefit from gene-therapy treatments. These treatments can be...

Read More
H.Res.794
Health Care, Animal Welfare
To Designate January 2020 as "National One Health Awareness Month"

Rep. Schrader and Rep. Ted Yoho (R-FL) introduced the bipartisan H. Res. 794 to designate January 2020 as “National One Health Awareness Month” to promote awareness of organizations focused on public ...

Read More
Health Care
Rep. Schrader Votes to Lower Drug Prices for Oregonians

Rep. Schrader Votes to Lower Drug Prices for Oregonians WASHINGTON, D.C. –Congressman Kurt Schrader (D-OR) voted today in the House of Representatives for HR 3, the Lower Drug Costs Now Act. This legi...

Read More
Health Care
Rep. Schrader Introduces Bill to Increase Drug Price Transparency and Reduce Gaming

For Immediate Release December 5, 2019 Contact: Larkin Parker, 202-225-5711 Rep. Schrader Introduces Bill to Increase Drug Price Transparency and Reduce Gaming WASHINGTON, D.C. –Congressman Kurt Schr...

Read More
H.R. 5304
Health Care
PBM Transparency in Prescription Drug Costs Act

Congressman Kurt Schrader (D-OR) introduced the bipartisan PBM Transparency in Prescription Drug Costs Act (HR 5304) with Congressman Greg Gianforte (R-MT). This bill will mandate quarterly reports on...

Read More
Health Care
Rep. Schrader Votes for Increased Transparency in Prescription Drug Pricing

For Immediate Release October 28, 2019 Contact: Larkin Parker, 202-225-5711 Rep. Schrader Votes for Increased Transparency in Prescription Drug Pricing WASHINGTON, D.C. –Congressman Kurt Schrader (OR...

Read More
Health Care
Rep. Schrader Introduces Bipartisan Bill to Make Biosimilar Drugs More Affordable for Patients

For Immediate Release September 20, 2019 Contact: Larkin Parker, 202-225-5711 Rep. Schrader Introduces Bipartisan Bill to Make Biosimilar Drugs More Affordable for Patients Congressman Kurt Schrader (...

Read More